DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Orthoclone Okt3 (Muromonab-CD3) - Epstein-Barr Virus Associated Lymphoproliferative Disorder - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Epstein-Barr Virus Associated Lymphoproliferative Disorder (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Orthoclone Okt3 (Muromonab-CD3) where reactions include epstein-barr virus associated lymphoproliferative disorder. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Orthoclone Okt3 side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01

Patient: 55 year old female

Reactions: Pleural Neoplasm, Fatigue, Pleural Effusion, Vascular Pseudoaneurysm, Protein Total Increased, Epstein-Barr Virus Associated Lymphoproliferative Disorder, Omentum Neoplasm, Haemobilia, Renal Neoplasm, Cytomegalovirus Hepatitis, Pneumonia, Dyspnoea, Plasmacytoma, Pancytopenia, Ascites, Globulins Increased, Asthenia, Herpes Virus Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: unk
    Indication: Immunosuppression
    Start date: 1987-08-01
    End date: 1987-09-01

Methylpednisolone Sodium Succinate
    Dosage: unknown dosage, taken for one month
    Indication: Immunosuppression
    Start date: 1987-07-01
    End date: 1987-08-01

Prednisone TAB
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 1987-09-01
    End date: 1988-02-01

Orthoclone Okt3
    Dosage: unk
    Indication: Immunosuppression

Prednisone TAB
    Dosage: 100 mg, x4 days
    Start date: 1988-02-01
    End date: 1988-02-01

Prednisone TAB
    Dosage: 20 mg, daily
    Start date: 1988-02-01
    End date: 1989-01-01

Cyclosporine
    Indication: Immunosuppression



Possible Orthoclone Okt3 side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-31

Patient: 46 year old female

Reactions: Anaemia, Epstein-Barr Virus Associated Lymphoproliferative Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tacrolimus
    Dosage: 4 to 6 ng/ml
    Indication: Renal and Pancreas Transplant Rejection

Orthoclone Okt3
    Indication: Renal and Pancreas Transplant Rejection

Mycophenolate Mofetil
    Administration route: Oral
    Indication: Renal and Pancreas Transplant Rejection

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017